A New Chapter in Health Technology: WELL Health Technologies and HEALWELL AI
Vancouver, BC, March 31, 2025 – In a recent press release, WELL Health Technologies Corp. (WELL) announced significant developments regarding their relationship with HEALWELL AI Inc. (HEALWELL). This update comes with the disclosure of new information, which is a material fact under both National Instrument 62-103 and 62-104.
The Call Option Agreement
On October 1, 2023, WELL and the founding shareholders of HEALWELL, Dr. Sven Grail and Dr. George Christodoulou, entered into a call option agreement (the “Call Option Agreement”). This agreement granted WELL a call option (the “Call Right”) to acquire up to 30.8 million Subordinate Voting Shares of HEALWELL (each, a “HEALWELL Share”) and 30.8 million Multiple Voting Shares of HEALWELL (each, a “MVS”).
Impact on WELL and the Founders
This call option represents a significant investment from WELL in HEALWELL, a leading AI health company. By acquiring these shares, WELL will gain a stronger foothold in the AI health sector, potentially enhancing their overall business strategy and growth prospects.
For Dr. Grail and Dr. Christodoulou, this agreement signifies the next step in the growth of HEALWELL. By aligning with a larger entity like WELL, they can potentially access more resources, expand their reach, and strengthen their position in the competitive health technology market.
Global Implications
The implications of this development extend beyond WELL and HEALWELL. As the use of AI in healthcare continues to grow, this partnership could set a precedent for other companies in the sector, encouraging collaboration and consolidation.
Moreover, the integration of AI in healthcare is poised to revolutionize the industry, offering more personalized care, improved diagnostics, and increased efficiency. This investment from WELL in HEALWELL is a testament to the potential of AI in healthcare and could inspire further innovation and investment in this space.
Conclusion
WELL Health Technologies’ call option agreement with HEALWELL AI Inc. marks an exciting development in the health technology sector. This partnership has the potential to strengthen WELL’s position in the industry, while also providing HEALWELL with valuable resources and increased reach. As the use of AI in healthcare continues to evolve, this investment could set a precedent for further collaboration and consolidation in the sector.
- WELL Health Technologies Corp. announces significant developments regarding their relationship with HEALWELL AI Inc.
- The Call Option Agreement grants WELL a call option to acquire up to 30.8 million shares and MVS from Dr. Grail and Dr. Christodoulou.
- This investment strengthens WELL’s position in the health technology sector and provides HEALWELL with valuable resources.
- The partnership could set a precedent for further collaboration and consolidation in the AI health sector.
